In vivo neutralization of inflammatory cytokines might not be necessary for regulatory T-cell immunotherapy [2]

Nature Reviews Immunology

Volumn 8, Issue 1, 2008, Pages

  Battaglia, Manuela ^a,b   Roncarolo, Maria Grazia ^a,c  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; RAPAMYCIN;

ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; DIABETIC PATIENT; DOWN REGULATION; EFFECTOR CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOTHERAPY; IN VIVO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 37549060390     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2138-c2     Document Type: Letter

References (12)

1. Roncarolo, M. G. & Battaglia, M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nature Rev. Immunol. 7, 585-598 (2007).
2. + T-cells in type 1 diabetes. Diabetes 54, 1407-1414 (2005).
3. + T-cell fraction. PLoS ONE 2, e146 (2007).
4. + T-cells from patients with type 1 diabetes. Diabetes 54, 92-99 (2005).
5. high regulatory T cells in human autoimmune diabetes. J. Autoimmun. 24, 55-62 (2005).
6. Gessl, A. & Waldhausl, W. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing. J. Clin. Endocrinol. Metab. 83, 2204-2209 (1998).
7. Roncarolo, M. G. et al. Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes. Clin. Immunol. Immunopathol. 49, 53-62 (1988).
8. + regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177, 8338-8347 (2006).
9. Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200, 277-285 (2004).
10. hi T-regulatory cells. Blood 108, 253-261 (2006).
11. Nadkarni, S., Mauri, C. & Ehrenstein, M. R. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J. Exp. Med. 204, 33-39 (2007).
12. Buch, M. H., Marzo-Ortega, H., Bingham, S. J. & Emery, P. Long-term treatment of rheumatoid arthritis with tumour necrosis factor α blockade: outcome of ceasing and restarting biologicals. Rheumatology (Oxford) 43, 243-244 (2004).